Orsus Therapeutics PLC

Proposed for strike-off13374907 Public limited company

Incorporated: 4 May 2021 (5 years)
Industry: Manufacture of other food products n.e.c. (10890)
Directors: Callum Richard Sommerton
Aditya Chathli
Dwight Patrick Mighty
Accounts type: Full
Region: Greater London
Address: 14 Belvoir Road
London
SE22 0QY

Filing status

Accounts due: 30 June 2026
Last accounts: 30 June 2024
Conf. stmt due: 21 July 2027
Last conf. stmt: 7 July 2026

Officers 4 active

Officer details are public data from the Companies House register.

Sommerton, Callum Richard

Director · Appointed 23 January 2025

Also at Mantle Resilience PLC, Creatdsupport Limited (proposed for strike-off)

British

Born November 1995

Mighty, Dwight

Secretary · Appointed 26 July 2022

Chathli, Aditya

Director · Appointed 4 May 2021

Also at Voyager Life Limited, Voyagercann Limited, Lokcom Networks Limited · more companies

British

Born May 1965 (61)

Mighty, Dwight Patrick

Director · Appointed 4 May 2021

Also at Voyager Life Limited, Voyagercann Limited, Orsus Labs Limited · more companies

British

Born October 1960 (66)

Officer history (2 former)

6 July 2026

Resigned Zuloff-Shani, Adi as Director

19 May 2025

Resigned Tulloch, Nicholas George Selby as Director

24 January 2025

Appointed Tulloch, Nicholas George Selby as Director

23 January 2025

Appointed Sommerton, Callum Richard as Director

26 July 2022

Appointed Mighty, Dwight as Secretary

16 November 2021

Appointed Zuloff-Shani, Adi as Director

4 May 2021

Appointed Chathli, Aditya as Director

4 May 2021

Appointed Mighty, Dwight Patrick as Director

Ownership 0 active

People and entities with significant control, from the Companies House PSC register

The company has declared that it has no person with significant control.

Former controllers (2)

6 June 2023

Ceased Aditya Chathli — Owns 25–50% of shares

6 June 2023

Ceased Dwight Patrick Mighty — Owns 25–50% of shares

Group structure 5 companies

Ownership group derived from the Companies House PSC register

Orsus Therapeutics PLC This company Proposed for strike-off

Amphora Health Ltd Owns 75–100% of shares

Orsus Labs Limited Owns 75–100% of shares

Voyager Life Limited Owns 75–100% of shares

Voyagercann Limited Owns 75–100% of shares

Filings 43

Date	Description	Made Up To
24 October 2026	Compulsory strike-off action has been suspended
29 September 2026	First Gazette notice for compulsory strike-off
17 July 2026	Termination of appointment of a director
17 July 2026	Confirmation statement with updates	7 July 2026
14 July 2026	Statement of capital following an allotment of shares